HB 2696

  • Oregon House Bill
  • 2019 Regular Session
  • Introduced in House Jan 14, 2019
  • House
  • Senate
  • Governor

Relating to the cost of prescription drugs.

Abstract

Establishes Drug Cost Review Commission to determine excess costs for certain prescription drugs and to set maximum payment rates for certain prescription drugs sold in this state by suppliers other than manufacturers. Requires investigation by Attorney General of complaints of payment rates that exceed payment rates established by commission. Adds new provisions considered unlawful trade practices.

Bill Sponsors (3)

Votes


No votes to display

Actions


Jul 01, 2019

House

In committee upon adjournment.

May 30, 2019

House

Informational Meeting held.

Jan 16, 2019

House

Referred to Health Care with subsequent referral to Ways and Means.

Jan 14, 2019

House

First reading. Referred to Speaker's desk.

Bill Text

Bill Text Versions Format
Introduced PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Oregon Legislative Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.